Alterations of RET oncogene in human adrenal tumors

Japanese Journal of Cancer Research

Volumn 89, Issue 6, 1998, Pages 634-640

  Lin, Shiu Ru ^a   Yang, Yuan Chieh ^a   Tsai, Juei Hsiung ^a   Hsu, Chin Hsun ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adrenal tumours; RET oncogene

Indexed keywords

ONCOPROTEIN; PROTEIN TYROSINE KINASE;

ADRENAL CORTEX TUMOR; ADRENAL TUMOR; ARTICLE; CLINICAL ARTICLE; CODON; CUSHING SYNDROME; EXON; FEMALE; GENE ACTIVATION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; MALE; ONCOGENE RET; PATHOGENESIS; PHEOCHROMOCYTOMA; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING;

EID: 0031817415     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb03265.x     Document Type: Article

References (31)

1. Takahashi, M., Ritz, J. and Cooper, G. M. Activation of a novel human transforming gene, RET, by DNA rearrangement. Cell, 42, 581-588 (1985).
2. Takahashi, M. and Cooper, G. M. RET transforming gene encodes a fusion protein homologous to tyrosine kinase. Mol. Cell. Biol. 7, 1378-1385 (1987).
3. Jing, S., Wen, D., Yu, Y., Holst, P. L., Luo, Y., Fang, M., Tamir, R., Antonio, L., Hu, Z., Altrock, B. W. and Fox, G. M. GDNF-induced activation of the RET protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF. Cell, 85, 1113-1124 (1996).
4. Kwok, J. B. J., Gardner, E., Watner, J. P., Ponder, B. A. J. and Mulligan, L. M. Structure analysis of the human RET proto-oncogene using exon trapping. Oncagene, 8, 2575-2582 (1993).
5. Mole, S. E., Mulligan, L. M., Healey, C. S., Ponder, B. A. and Tunnaelitte, A. Localization of the gene for multiple endocrine neoplasia type 2A to a 480 kb region in chromosome band 10q11.2. Hum. Mol. Genet., 2, 247-252 (1993).
6. Grieco, M., Santoro, M., Berlingieri, M. T., Melillo, R. M., Donghi, R., Bongarzone, I. Pierotti, M. A., Della Porta, G., Fusco, A. and Vecchio, G. PTC is a novel rearranged form of the RET proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell, 60, 557-563 (1990).
7. Ishizaka, Y., Ushijima, T., Sugimura, T. and Nagao, M. cDNA cloning and characterization of RET activated in human papillary thyroid carcinoma cell line. Biochem. Biophys. Res. Commun., 168, 402-408 (1990).
8. Lanzi, C., Borrello, M. G., Bongarzone, I., Migliazza, A., Fusco, A., Grieco, M., Santoro, M., Gambetta, R. A., Zunino, F. and Della Porta, G. Identification of the product of two oncogenic rearranged forms of the RET protooncogene in papillary thyroid carcinomas. Ontogene, 13, 358-366 (1992).
9. Bongarzone, I., Monzini, N., Borrello, M. G., Carcano, C., Ferraresi, G., Arighi, E., Mondellini, P., Della Porta, G. and Pierotti, M. A. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of RKT tyrosine kinase and the regulatory subunit RIα of cyclic Amp-dependent protein kinase A. Mol. Cell. Biol., 13, 358-366 (1993).
10. Sozzi, G., Bongarzone, I., Miozzo, M., Borrello, M. G., Blutti, M. G., Pilotti, S., Della Porta, G. and Pierotti, M. A. At (10, 17) translocation creates the RET/PTC2 chimeric transforming sequence in papillary thyroid carcinoma. Genes Chromosom. Cancer, 9, 244-250 (1994).
11. Jhiang, S. M., Smanik, P. A. and Mazzaferri, E. L. Development of a single-step duplex RT-PCR detecting different forms of RET activation, and identification of the third form of in vivo RET activation in human papillary thyroid carcinoma. Cancer Lett., 78, 69-76 (1994).
12. Bongarzone, I., Butti, M. G., Coronelli, S., Borrello, M. G., Santoro, M., Mondellini, P., Pilotti, S., Fusco, A., Della Porta, G. and Pierotti, M. A. Frequent activation of RET proto-oncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res., 54, 2979-2985 (1994).
13. Bongarzone, I., Pierotti, M. A., Monzini, N., Mondellini, P., Manenti, G., Donghi, R., Pilotti, S., Grieco, M., Santoro, M., Fusco, A., Vecchio, G. and Della Porta, G. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene, 4, 1457-1462 (1989).
14. Santoro, M., Carlomagno, F., Hay, I, D., Herrmann, M. A., Grieco, M., Melillo, R., Pierotti, M. A., Bongarzone, I., Della Porta, G., Berger, N., Peix, J. L., Paulin, C., Fabien, N., Vecchio, G., Jenkins, R. B. and Fusco, A. RET oncogene activation in human thyroid neoplasms is restricted to the papillary carcinoma subtype. J. Clin. Invest., 89, 1517-1522 (1992).
15. Ishizaka, Y., Kobayashi, S., Ushijima, T., Sugimura, T. and Nagao, M. Detection of RET/PTC transcripts in thyroid adenomas and adenomarous goiter by an RT-PCR method. Oncogene, 6, 1667-1672 (1991).
16. Wajjwalku, W., Nakamura, S., Hasegawa, Y., Miyazaki, K., Satoh, Y., Funahashi, H., Matsuyuma, M. and Takahashi, M. Low frequency of rearrangement of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas. Jpn. J. Cancer Res., 83, 671-675 (1992).
17. Jhiang, S. M., Caruso, D. R., Gilmore, E., Ishizaka, Y., Tahira, T., Nagao, M., Chiu, I. M. and Mazzaferri, E. L. Detection of the PTC RET oncogene in human thyroid cancers. Oncogene, 7, 1331-1337 (1992).
18. Zou, M., Shi, Y. and Farid, N. R. Low rate of RET protooncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia. Cancer, 73, 176-180 (1994).
19. Ricardo, V. L. RET proto-oncogene mutations and rearrangements in endocrine diseases. Am. J. Pathol., 147, 1539-1544 (1995).
20. David, N., Kovac, W. J. and DeBold, R. The adrenal cortex. In "Williams Textbook of Endocrinology," ed. J. D. Wilson and D. W. Foster, pp. 489-619 (1992). Saunders, Philadelphia.
21. Landsberg, L. and Young, J. B. Catecholamines and the adrenal medulla. In "Williams Textbook of Endocrinology." ed. J. D. Wilson and D. W. Foster, pp. 621-705 (1992). Saunders, Philadelphia.
22. Blin, N. and Stafford, D. M. A general method for isolation of high-molecular-weight DNA from eukaryotes. Nucleic Acids Res., 3, 2303-2308 (1976).
23. Chomczynski, P. and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem., 162, 156-159 (1987).
24. Santoro, M., Sabino, N., Ishizaka, Y., Ushijima, T., Carlomagno, F., Cerrato, A., Grieco, M., Battaglia, C., Martelli, M. E., Paulin, C., Fabien, N., Sugimura, T., Fusco, A. and Nagao, M. Involvement of RET oncogene in human tumours, specificity of RET activation to thyroid tumours. Br. J. Cancer, 8, 460-464 (1993).
25. Church, G. M. and Gilbert, W. Genomic sequencing. Proc. Natl. Acad. Sci. USA, 81, 1991-1995 (1984).
26. Mulligan, L. M. and Ponder, B. A. J. Genetic basis of endocrine disease, multiple endocrine neoplasia type 2. J. Clin. Endocrinol. Metab., 80, 1989-1995 (1995).
27. Lips, C. J. M., Landsvater, R. M., Hoppener, J. W. M., Geerdink, R. A., Blijham, G., Jansen-Schillhorm, von Veen, J. M., Van Gils, A. P. G., Dewit, M. J., Zewald, R. A., Berends, M. J. H., Breemer, F. A., Brouwers-Smalbraak, J., Jansen, R. P. M., van Amstel, H. K. P., van Vroonhoven, T. J. M. M. and Vroom, T. M. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N. Engl. J. Med., 331, 828-835 (1994).
28. Mulligan, L. M., Kwok, J. B., Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., Love, D. R., Mole, S. E., Moure, J. K., Papi, L., Ponder, M. A., Teleniu, H., Tunnacliffe, A. and Ponder, B. A. J. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature, 363, 458-460 (1993).
29. Santoro, M., Carlomagno, F., Romano, A., Bottaro, D. P., Dathan, N. A., Grieco, M., Fusco, A., Vecchio, G., Matoskova, B., Kraushi, H. and Difiore, P. P. Activation of RET as a dominant transforming gene by germ line mutations of MEN 2A and MEN 2B. Science, 267, 381-383 (1995).
30. Romeo, G., Ranchetto, P., Yin, L., Barone, V., Seri, M., Ceccherini, I., Pasini, B., Bocciardi, R., Lerone, M., Kaariainen, H. and Martucciello, G. Point mutations affecting the tyrosine kinase domain of the RET protooncogene in Hirschsprung's disease. Nature, 367, 377-378 (1994).
31. Edery, P., Lyonnet, S., Mulligan, L. M., Pelet, A., Dow, E., Abel, L., Holder, S., Nihouse-Fekete, C., Ponder, B. A. J. and Munnich, A. Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature, 367, 378-380 (1994).